drugset / Trial / NCT01102257

Dry Eye Assessment and Management: Feasibility Study

NCT01102257 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to test a protocol investigating the efficacy of omega-3 fatty acids in treating dry eye disease. The study is termed "feasibility" because its purpose is to demonstrate an ability to execute the proposed protocol with compliance at two sites rather than generate statistically relevant data concerning the safety and efficacy of the supplement in patients with dry eye disease.

Timeline

Start
2010-01
Primary completion
2010-07
Completion
2011-03

Outcome

Met primary endpoint

registry analysis (superiority or other test); Omega-3 Supplement vs Olive Oil; p = 0.03; Wilcoxon (Mann-Whitney) NCT01102257 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Omega-3 EFA Supplement Unknown 3 g —

Indications